Wednesday, January 22, 2025

Testosterone therapy may protect against breast cancer in trans masculine individuals

a) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly correlated with increasing degrees of lobular atrophy. c) Stromal composition was assessed by the pathologists using three categories. d) There was no correlation between duration of TT and stromal composition as assessed by the pathologists. Credit: Breast Cancer Research (2024). DOI: 10.1186/s13058-024-01867-w In a recent study, investigators at Beth Israel Deaconess Medical Center (BIDMC) led by Jan Heng, Ph.D., examined the effects of testosterone therapy in the breast tissue of 425 trans masculine individuals. Leveraging an artificial intelligence algorithm created by Read More

No comments:

Post a Comment